Methods for selecting microbes from a diverse genetically modified library to detect and optimize the production of metabolites

Patent metadata

Field	Value
Publication number	US-11603528-B2
Application number	US-201916718736-A
Country	US
Kind code	B2
Filing date	Dec 18, 2019
Priority date	Mar 14, 2013
Publication date	Mar 14, 2023
Grant date	Mar 14, 2023

Abstract

The present invention relates to genetically modified bacteria and methods of optimizing genetically modified bacteria for the production of a metabolite.

First claim

What is claimed is:

1. A method of selecting a subset of microbes for the production of a metabolite comprising
placing a population of microbes in an environment of a toxin, wherein the toxin is external to the population of microbes,
wherein the population of microbes produces a sensor biomolecule that regulates production of an antidote to a toxin,
wherein the population of microbes produces a metabolite binding partner of the sensor biomolecule, which binds to the sensor to induce production of the antidote in a manner dependent on the concentration of the produced metabolite,
wherein the toxin and antidote pair is selected from the group consisting of SDS:tolC, colicin:tolC (negative selection), kanamycin:kanamycin nucleotidyltransferase, chloramphenicol:
chloramphenicol acyl transferase, ampicillin:beta lactamase, tetracycline:tetracycline efflux pump tetA, nickel chloride:tetracycline efflux pump tetA (negative selection), and 5-fluoroorotic acid:URA3 (negative selection), and
selecting a subset of microbes that produce sufficient metabolite to prevent microbe death.

2. The method of claim 1 further comprising
genetically modifying the subset of microbes to alter genes that affect production of the metabolite directly or indirectly,
subjecting the subset of microbes to a subsequent environment of the toxin having a concentration greater than the previous environment,
and selecting a subsequent subset of microbes the produce sufficient metabolite to prevent microbe death.

3. The method of claim 2 further comprising repeating in sequence: (1) genetically modifying the subsequent subset of microbes by altering genes that affect the production of the metabolite, (2) subjecting the genetically altered microbes to a subsequent environment of a toxin having a concentration greater than a previous environment, and (3) selecting a further subsequent subset of microbes that produce sufficient metabolite to prevent microbe death, said repeating step resulting in optimized metabolite producing microbes.

4. The method of claim 1 wherein binding of the metabolite to the sensor regulates production of the antidote in a manner dependent on the concentration of the produced metabolite.

5. The method of claim 4 wherein a positive selection marker is used to select the subset of microbes that produce sufficient metabolite to prevent microbe death.

6. The method of claim 4 wherein the sensor regulates production of two or more antidotes independently and two or more toxins are used to select the subset of microbes that produce sufficient metabolite to prevent microbe death.

7. The method of claim 4 wherein a negative selection marker is used to eliminate false positives that detoxify the microbe despite not producing sufficient metabolite.

8. The method of claim 1 wherein the population of microbes has been genetically modified to encode two or more redundant copies of the sensor in order to reduce false positives.

9. The method of claim 1 wherein the sensor also regulates its own expression through a cognate nucleic acid sequence located 5′ to the DNA sequence encoding the sensor in order to reduce false positives.

10. The method of claim 1 wherein the degradation rate of the antidote is increased by a degradation signal attached to the antidote in order to reduce false positives.

11. The method of claim 2 wherein the step of genetically modifying the subset of microbes to alter genes that produce the metabolite includes multiplexed automated genome engineering.

12. The method of claim 2 wherein the step of genetically modifying the subset of microbes includes making a plasmid library of pathway genes.

13. The method of claim 2 wherein the step of genetically modifying the subset of microbes includes making a plasmid library of genomic fragments of any organism.

14. The method of claim 2 wherein the step of genetically modifying the subset of microbes includes making a plasmid library of metagenomic sequences.

15. The method of claim 11 wherein the multiplexed automated genome engineering includes reducing spontaneous background mutants.

16. The method of claim 11 wherein the multiplexed automated genome engineering includes reducing spontaneous background mutants by pretreatment with a negative selector.

17. The method of claim 1 wherein concentration of the metabolite exposed to the sensor is attenuated.

18. The method of claim 17 wherein the concentration of the metabolite exposed to the sensor is attenuated by expressing one or more proteins to export the metabolite outside of the cell.

19. The method of claim 17 wherein the concentration of the metabolite exposed to the sensor is attenuated by expressing one or more enzymes that convert the metabolite to another metabolite having less interaction with the sensor.

20. The method of claim 17 wherein the concentration of the metabolite exposed to the sensor is attenuated by expressing a biomolecule that binds to the metabolite and reduces its interaction with the sensor.

Assignees

• Harvard College

Inventors

• Church George M
• Raman Srivatsan
• Taylor Noah D
• Rogers Jameson K

Classifications

• C12N1/38

  Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N1/34 takes precedence) · CPC title

• C12P13/227

  Tryptophan · CPC title

• C12P17/06

  containing a six-membered hetero ring, e.g. fluorescein · CPC title

• C12P19/42

  Cobalamins, i.e. vitamin B12, LLD factor · CPC title

• C12P17/188

  Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms (ergot-alcaloids C12P17/183) · CPC title